Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Terry FurlongPaul J Martin

Abstract

In 2 consecutive prospective clinical trials, we evaluated the efficacy of sirolimus together with a calcineurin inhibitor (cyclosporine or tacrolimus) and low-dose methotrexate for prevention of graft-versus-host disease (GVHD) after unrelated hematopoietic cell transplantation (HCT). Nine patients received sirolimus with cyclosporine, and 17 received sirolimus with tacrolimus. The incidence of grade II-IV GVHD was 77%, with the median onset at day 7 after HCT. Because of toxicity, administration of sirolimus was discontinued earlier than planned in 11 patients, but after the onset of GVHD. Three patients developed renal failure requiring hemodialysis. Accrual in both studies was terminated because of lack of efficacy. In these studies, the addition of sirolimus to regimens containing a calcineurin inhibitor and methotrexate appeared to cause toxicity and provided no detectable improvement in preventing GVHD.

References

May 1, 1991·Immunology Today·R E Morris
Mar 4, 1993·The New England Journal of Medicine·N A KernanJ McCullough
Apr 2, 1998·The New England Journal of Medicine·J A HansenC Anasetti
May 14, 2003·Transplantation Proceedings·S N Sehgal
May 14, 2003·Transplantation Proceedings·J F Trotter
Apr 28, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Paul J MartinRainer Storb
Apr 28, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Corey CutlerJoseph H Antin
May 15, 2004·British Journal of Haematology·Meghan A Higman, Georgia B Vogelsang
Dec 31, 2004·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Laura J JohnstonNelson J Chao
Dec 13, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Alexandra H FilipovichMary E D Flowers

❮ Previous
Next ❯

Citations

Nov 11, 2008·Bone Marrow Transplantation·R RamO Shpilberg
Jan 20, 2009·Bone Marrow Transplantation·K HocheggerJ Clausen
Dec 8, 2009·Bone Marrow Transplantation·D HodaM A Kharfan-Dabaja
Aug 19, 2010·Current Opinion in Hematology·Corey Cutler, Joseph H Antin
Feb 27, 2009·Current Opinion in Pediatrics·Jeffery J Auletta, Kenneth R Cooke
Jun 25, 2014·Nature Reviews. Clinical Oncology·Sung Won Choi, Pavan Reddy
Oct 23, 2008·Expert Review of Hematology·John Koreth, Joseph H Antin
Sep 28, 2010·Expert Review of Hematology·Boglarka GyurkoczaRainer F Storb
Jul 10, 2012·Expert Opinion on Pharmacotherapy·Andrew R Rezvani, Rainer F Storb
Jun 24, 2009·Expert Opinion on Drug Metabolism & Toxicology·Kara Fortune, Daniel Couriel
May 18, 2016·International Journal of Hematologic Oncology·Erin Gatza, Sung Won Choi
Oct 28, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Rainer StorbCorey Cutler
Sep 30, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·David S SnyderStephen J Forman
Jul 10, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ahmed AbouelnasrSilvy Lachance
Jun 20, 2012·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Zaid Al-KadhimiJoseph Uberti
Dec 21, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Christian JunghanssSandra Lange
Jan 13, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Uwe PlatzbeckerMartin Bornhäuser
Jul 22, 2008·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Daniel WolffChristian Junghanss
Apr 11, 2007·Advances in Cancer Research·Olle Ringdén
May 21, 2021·Frontiers in Immunology·Justin LokeCharles Craddock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Daniel WolffChristian Junghanss
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
U PlatzbeckerM Bornhäuser
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
Lindsay L RosenbeckSherif S Farag
© 2022 Meta ULC. All rights reserved